Qube Research & Technologies LTD Alzamend Neuro, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.82 - $1.2 $64,341 - $94,158	-78,465 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.91 - $2.23 $71,403 - $174,976	78,465 New	78,465 $97,000
Q4 2021 Feb 01, 2022	SELL	$1.9 - $3.08 $96,618 - $156,624	-50,852 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.28 - $7.68 $115,942 - $390,543	50,852 New	50,852 $157,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $115M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.